150 related articles for article (PubMed ID: 18614773)
1. Cost-effectiveness of frequent in-center hemodialysis.
Lee CP; Zenios SA; Chertow GM
J Am Soc Nephrol; 2008 Sep; 19(9):1792-7. PubMed ID: 18614773
[TBL] [Abstract][Full Text] [Related]
2. Renal transplantation vs hemodialysis: cost-effectiveness analysis.
Perović S; Janković S
Vojnosanit Pregl; 2009 Aug; 66(8):639-44. PubMed ID: 19780419
[TBL] [Abstract][Full Text] [Related]
3. Health economic evaluations: the special case of end-stage renal disease treatment.
Winkelmayer WC; Weinstein MC; Mittleman MA; Glynn RJ; Pliskin JS
Med Decis Making; 2002; 22(5):417-30. PubMed ID: 12365484
[TBL] [Abstract][Full Text] [Related]
4. Patient Preferences for Longer or More Frequent In-Center Hemodialysis Regimens: A Multicenter Discrete Choice Study.
Fotheringham J; Vilar E; Bansal T; Laboi P; Davenport A; Dunn L; Hole AR
Am J Kidney Dis; 2022 Jun; 79(6):785-795. PubMed ID: 34699958
[TBL] [Abstract][Full Text] [Related]
5. Cost-Effectiveness of High Dose Hemodialysis in Comparison to Conventional In-Center Hemodialysis in the Netherlands.
Beby AT; Cornelis T; Zinck R; Liu FX
Adv Ther; 2016 Nov; 33(11):2032-2048. PubMed ID: 27664108
[TBL] [Abstract][Full Text] [Related]
6. To reuse or not to reuse? An economic evaluation of hemodialyzer reuse versus conventional single-use hemodialysis for chronic hemodialysis patients.
Manns BJ; Taub K; Richardson RM; Donaldson C
Int J Technol Assess Health Care; 2002; 18(1):81-93. PubMed ID: 11987444
[TBL] [Abstract][Full Text] [Related]
7. An empiric estimate of the value of life: updating the renal dialysis cost-effectiveness standard.
Lee CP; Chertow GM; Zenios SA
Value Health; 2009; 12(1):80-7. PubMed ID: 19911442
[TBL] [Abstract][Full Text] [Related]
8. Cost analysis of dialysis treatments for end-stage renal disease (ESRD).
Goeree R; Manalich J; Grootendorst P; Beecroft ML; Churchill DN
Clin Invest Med; 1995 Dec; 18(6):455-64. PubMed ID: 8714789
[TBL] [Abstract][Full Text] [Related]
9. Cost-effectiveness of haemodialysis and peritoneal dialysis for patients with end-stage renal disease in Singapore.
Yang F; Lau T; Luo N
Nephrology (Carlton); 2016 Aug; 21(8):669-77. PubMed ID: 26566750
[TBL] [Abstract][Full Text] [Related]
10. Cost calculations during "dire straits": a cost-of-illness analysis of regular hemodialysis for end-stage renal disease in Greece.
Naoum P; Topkaroglou I; Kitsonis D; Skroumpelos A; Athanasakis K; Iatrou C; Boletis J; Kyriopoulos J
Int J Artif Organs; 2016 Feb; 39(2):87-9. PubMed ID: 26953901
[TBL] [Abstract][Full Text] [Related]
11. Economic evaluation of palliative management versus peritoneal dialysis and hemodialysis for end-stage renal disease: evidence for coverage decisions in Thailand.
Teerawattananon Y; Mugford M; Tangcharoensathien V
Value Health; 2007; 10(1):61-72. PubMed ID: 17261117
[TBL] [Abstract][Full Text] [Related]
12. Cost Effectiveness of Dialysis Modalities: A Systematic Review of Economic Evaluations.
Howell M; Walker RC; Howard K
Appl Health Econ Health Policy; 2019 Jun; 17(3):315-330. PubMed ID: 30714086
[TBL] [Abstract][Full Text] [Related]
13. In-center hemodialysis six times per week versus three times per week.
; Chertow GM; Levin NW; Beck GJ; Depner TA; Eggers PW; Gassman JJ; Gorodetskaya I; Greene T; James S; Larive B; Lindsay RM; Mehta RL; Miller B; Ornt DB; Rajagopalan S; Rastogi A; Rocco MV; Schiller B; Sergeyeva O; Schulman G; Ting GO; Unruh ML; Star RA; Kliger AS
N Engl J Med; 2010 Dec; 363(24):2287-300. PubMed ID: 21091062
[TBL] [Abstract][Full Text] [Related]
14. [REIN Report 2011--summary].
Couchoud C; Lassalle M; Jacquelinet C
Nephrol Ther; 2013 Sep; 9 Suppl 1():S3-6. PubMed ID: 24119584
[TBL] [Abstract][Full Text] [Related]
15. Markov Chain Monte Carlo simulation for projection of end stage renal disease patients in Greece.
Rodina-Theocharaki A; Bliznakova K; Pallikarakis N
Comput Methods Programs Biomed; 2012 Jul; 107(1):90-6. PubMed ID: 22024418
[TBL] [Abstract][Full Text] [Related]
16. The dilemmas of patient treatment for end-stage renal disease.
Schmidt RW; Blumenkrantz M; Wiegmann TB
Am J Kidney Dis; 1983 Jul; 3(1):37-47. PubMed ID: 6346866
[TBL] [Abstract][Full Text] [Related]
17. Cost-effective care of end-stage renal disease: a billion dollar question.
Roberts SD; Maxwell DR; Gross TL
Ann Intern Med; 1980 Feb; 92(2 Pt 1):243-8. PubMed ID: 6766290
[TBL] [Abstract][Full Text] [Related]
18. The impact of home nocturnal hemodialysis on end-stage renal disease therapies: a decision analysis.
McFarlane PA; Bayoumi AM; Pierratos A; Redelmeier DA
Kidney Int; 2006 Mar; 69(5):798-805. PubMed ID: 16407887
[TBL] [Abstract][Full Text] [Related]
19. Economic evaluation of hemodialysis: implications for technology assessment in Greece.
Kaitelidou D; Ziroyanis PN; Maniadakis N; Liaropoulos LL
Int J Technol Assess Health Care; 2005; 21(1):40-6. PubMed ID: 15736513
[TBL] [Abstract][Full Text] [Related]
20. Lifetime cost-effectiveness analysis of first-line dialysis modalities for patients with end-stage renal disease under peritoneal dialysis first policy.
Wong CKH; Chen J; Fung SKS; Mok M; Cheng YL; Kong I; Lo WK; Lui SL; Chan TM; Lam CLK
BMC Nephrol; 2020 Feb; 21(1):42. PubMed ID: 32019528
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
